This topic contains a solution. Click here to go to the answer

Author Question: A nurse is performing a shift assessment on a patient. While collecting objective and subjective ... (Read 89 times)

Melani1276

  • Hero Member
  • *****
  • Posts: 516
A nurse is performing a shift assessment on a patient. While collecting objective and subjective data, the nurse identifies as objective data that
 
  1. The patient reports feelings of depression.
  2. The patient demonstrates facial grimacing.
  3. The patient complains of feeling nauseated.
  4. The patient complains of visual disturbances.

Question 2

A nurse admits a patient and selects the priority nursing diagnosis of acute pain. The nurse plans to administer pain medication as needed. When the patient complains of pain, the nurse medicates the patient. Next, the nurse should
 
  1. Assess the patient's laboratory values.
  2. Create a new nursing diagnosis.
  3. Administer an additional dose of medication.
  4. Evaluate the effects of the medication.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Ashley I

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

ANS: 2

Answer to Question 2

ANS: 4




Ashley I

  • Sr. Member
  • ****
  • Posts: 344

 

Did you know?

Excessive alcohol use costs the country approximately $235 billion every year.

Did you know?

The top five reasons that children stay home from school are as follows: colds, stomach flu (gastroenteritis), ear infection (otitis media), pink eye (conjunctivitis), and sore throat.

Did you know?

Asthma cases in Americans are about 75% higher today than they were in 1980.

Did you know?

Most strokes are caused when blood clots move to a blood vessel in the brain and block blood flow to that area. Thrombolytic therapy can be used to dissolve the clot quickly. If given within 3 hours of the first stroke symptoms, this therapy can help limit stroke damage and disability.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

For a complete list of videos, visit our video library